« Back to Record
Citation APA

Honoré, P. P., Gutierrez, L. B., Kugener, L., Redant, S., Attou, R., Gallerani, A., & De Bels, D. (2020). Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: Perhaps some potential confounders to consider. Critical care, 24(1), 603. doi:10.1186/s13054-020-03294-7


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/313886

Honoré, P. P., Gutierrez, L. B., Kugener, L., Redant, S., Attou, R., Gallerani, A., & De Bels, D. (2020). Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: Perhaps some potential confounders to consider. Critical care, 24(1), 603. doi:10.1186/s13054-020-03294-7